AI-assisted, human-published

08/10/2026 /Funding Events

Expedition Therapeutics Raises $115 Million in Series B Funding for Drug Development

Expedition Therapeutics closes an oversubscribed $115 million Series B financing, led by General Atlantic, to advance oral small molecule therapies for inflammatory and respiratory diseases.

AI-assisted, human-published

Latest headlines







join us

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here

©2023 VentureCapital.com